StonvexLoading…
StonvexStonvexStonvexCore line items from CRH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $7.37B | $37.45B | $28.03B | $16.96B |
Operating Income | $-38.00M | $5.44B | $4.03B | $1.95B |
Net Income | $-176.00M | $3.75B | $2.73B | $1.23B |
EPS (Diluted) | $-0.27 | $5.51 | $3.99 | $1.78 |
Total Assets | $58.17B | $58.33B | $58.53B | $53.98B |
Total Liabilities | $33.62B | $32.85B | $33.90B | $30.35B |
Cash & Equivalents | $3.24B | $4.10B | $4.20B | $2.88B |
Free Cash Flow OCF − CapEx | $-1.22B | $2.91B | $818.00M | $-581.00M |
Shares Outstanding | 704.02M | 706.95M | 709.05M | 711.79M |